These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 2250765

  • 21. Release of prostaglandin E2 and beta-endorphin-like immunoreactivity from rat adenohypophysis in vitro: variations after adrenalectomy or lesions of the paraventricular nuclei.
    Knepel W, Vlaskovska M, Meyer DK.
    Brain Res; 1985 Feb 04; 326(1):87-94. PubMed ID: 3155985
    [Abstract] [Full Text] [Related]

  • 22. Corticotrophin-releasing factors in the hypothalamus of the developing fetal sheep.
    Currie IS, Brooks AN.
    J Dev Physiol; 1992 May 04; 17(5):241-6. PubMed ID: 1281183
    [Abstract] [Full Text] [Related]

  • 23. Angiotensin II and ACTH release: site of action and potency relative to corticotropin releasing factor and vasopressin.
    Spinedi E, Negro-Vilar A.
    Neuroendocrinology; 1983 Dec 04; 37(6):446-53. PubMed ID: 6318148
    [Abstract] [Full Text] [Related]

  • 24. Corticotropin releasing factor (CRF): effects on the release of pro-opiomelanocortin (POMC)-related peptides by human anterior pituitary cells in vitro.
    Chan JS, Lu CL, Seidah NG, Chretien M.
    Endocrinology; 1982 Oct 04; 111(4):1388-90. PubMed ID: 6288359
    [Abstract] [Full Text] [Related]

  • 25. Vasoactive intestinal peptide and corticotropin-releasing hormone increase beta-endorphin release and proopiomelanocortin messenger RNA levels in primary cultures of hypothalamic cells: effects of acute and chronic ethanol treatment.
    Poplawski MM, Boyadjieva N, Sarkar DK.
    Alcohol Clin Exp Res; 2005 Apr 04; 29(4):648-55. PubMed ID: 15834231
    [Abstract] [Full Text] [Related]

  • 26. Ontogeny of pituitary responsiveness to corticotropin-releasing hormone in rat.
    Hotta M, Shibasaki T, Masuda A, Imaki T, Demura H, Ohno H, Daikoku S, Benoit R, Ling N, Shizume K.
    Regul Pept; 1988 Jun 04; 21(3-4):245-52. PubMed ID: 3261876
    [Abstract] [Full Text] [Related]

  • 27. Feedback inhibition of opioid peptide release in the hypothalamus of the rat.
    Nikolarakis KE, Almeida OF, Herz A.
    Neuroscience; 1987 Oct 04; 23(1):143-8. PubMed ID: 2891081
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Arginine8 vasopressin potentiates the beta-endorphin-releasing activity of ovine corticotropin-releasing factor (oCRF) in vitro.
    Culler MD, Turkelson CM, Thomas CR, Arimura A.
    Proc Soc Exp Biol Med; 1983 Jun 04; 173(2):264-9. PubMed ID: 6306671
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. In vivo and in vitro effects of arginine-vasopressin receptor antagonists on the hypothalamic-pituitary-adrenal axis in the rat.
    Bernardini R, Chiarenza A, Kamilaris TC, Renaud N, Lempereur L, Demitrack M, Gold PW, Chrousos GP.
    Neuroendocrinology; 1994 Nov 04; 60(5):503-8. PubMed ID: 7845540
    [Abstract] [Full Text] [Related]

  • 32. Changes in ACTH and beta-endorphin immunoreactivity in immune tissues during a chronic inflammatory stress are not correlated with changes in corticotropin-releasing hormone and arginine vasopressin.
    Jessop DS, Renshaw D, Lightman SL, Harbuz MS.
    J Neuroimmunol; 1995 Jul 04; 60(1-2):29-35. PubMed ID: 7642745
    [Abstract] [Full Text] [Related]

  • 33. Central bombesin activates the hypothalamic-pituitary-adrenal axis. Effects on regional levels and release of corticotropin-releasing hormone and arginine-vasopressin.
    Kent P, Anisman H, Merali Z.
    Neuroendocrinology; 2001 Mar 04; 73(3):203-14. PubMed ID: 11307039
    [Abstract] [Full Text] [Related]

  • 34. Concomitant changes in the in vitro and in vivo release of opioid peptides and luteinizing hormone-releasing hormone from the hypothalamus following blockade of receptors for corticotropin-releasing factor.
    Nikolarakis KE, Almeida OF, Sirinathsinghji DJ, Herz A.
    Neuroendocrinology; 1988 Jun 04; 47(6):545-50. PubMed ID: 2840600
    [Abstract] [Full Text] [Related]

  • 35. Stimulation of hypothalamic beta-endorphin and dynorphin release by corticotropin-releasing factor (in vitro).
    Nikolarakis KE, Almeida OF, Herz A.
    Brain Res; 1986 Dec 03; 399(1):152-5. PubMed ID: 2879612
    [Abstract] [Full Text] [Related]

  • 36. Ghrelin is released from rat hypothalamic explants and stimulates corticotrophin-releasing hormone and arginine-vasopressin.
    Mozid AM, Tringali G, Forsling ML, Hendricks MS, Ajodha S, Edwards R, Navarra P, Grossman AB, Korbonits M.
    Horm Metab Res; 2003 Aug 03; 35(8):455-9. PubMed ID: 12953161
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Beta-endorphin and adrenocorticotropin release from rat adenohypophysis in vitro: evidence for local modulation by arachidonic acid metabolites of the cyclooxygenase and lipoxygenase pathway.
    Vlaskovska M, Knepel W.
    Neuroendocrinology; 1984 Oct 03; 39(4):334-42. PubMed ID: 6092988
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.